Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Effects of Serine-129 Phosphorylation on Alpha-Synuclein Strains
EF 2021-22
Résumé
A variety of neurodegenerative diseases, such as Parkinsons Disease or Lewy Body Dementia, are attributed to the same root cause - an abnormal clustering of a protein called alpha-synuclein. It is unknown how clusters of the same protein can result in multiple different diseases. The best explanation for this is that different shapes of clusters cause different diseases. Our lab has previously determined that by simply adding salt, different shapes of clusters can be formed compared to when these clusters form without salt. We have shown that salt and no salt clusters form at different rates and are broken-up by enzymes differently, among other characteristics. Additionally, the salt and no salt clusters can cause different symptoms at different time points when injected into mice. This supports the idea that different diseases are caused by different shapes of clusters. An interesting note is that alpha-synuclein clusters collected from patients with Parkinsons Disease or Lewy Body Dementia, are primarily made of alpha-synuclein that is modified by the addition of a phosphate to the protein. This raises questions about how the addition of the phosphate could impact the shape and properties of the clusters. This study will make alpha synuclein clusters of both the normal and the modified protein to determine how the addition of a phosphate group changes the cluster shape. In both cases, the clusters will be made using salt, to allow comparison to our previous work. This will provide us a more complete understanding of potential differences in the shape of alpha-synuclein clusters under different conditions. This knowledge could then contribute to drug research to specifically treat Parkinsons Disease or Lewy Body Dementia.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466743
Name
Silver Nicholas R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effects of Serine-129 Phosphorylation on Alpha-Synuclein Strains
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alpha-Synuclein; Neurodegenerative Diseases; Parkinson'S Disease; Protein Aggregate Strains; Synucleinopathies
Abstract
A variety of neurodegenerative diseases, such as Parkinsons Disease or Lewy Body Dementia, are attributed to the same root cause - an abnormal clustering of a protein called alpha-synuclein. It is unknown how clusters of the same protein can result in multiple different diseases. The best explanation for this is that different shapes of clusters cause different diseases. Our lab has previously determined that by simply adding salt, different shapes of clusters can be formed compared to when these clusters form without salt. We have shown that salt and no salt clusters form at different rates and are broken-up by enzymes differently, among other characteristics. Additionally, the salt and no salt clusters can cause different symptoms at different time points when injected into mice. This supports the idea that different diseases are caused by different shapes of clusters. An interesting note is that alpha-synuclein clusters collected from patients with Parkinsons Disease or Lewy Body Dementia, are primarily made of alpha-synuclein that is modified by the addition of a phosphate to the protein. This raises questions about how the addition of the phosphate could impact the shape and properties of the clusters. This study will make alpha synuclein clusters of both the normal and the modified protein to determine how the addition of a phosphate group changes the cluster shape. In both cases, the clusters will be made using salt, to allow comparison to our previous work. This will provide us a more complete understanding of potential differences in the shape of alpha-synuclein clusters under different conditions. This knowledge could then contribute to drug research to specifically treat Parkinsons Disease or Lewy Body Dementia.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Silver, Nicholas R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~